Prestige Consumer Healthcare
PBH
#4787
Rank
NZ$3.85 B
Marketcap
NZ$81.28
Share price
-0.83%
Change (1 day)
-24.97%
Change (1 year)

EPS for Prestige Consumer Healthcare (PBH)

EPS in 2026 (TTM): NZ$6.73

According to Prestige Consumer Healthcare's latest financial reports the company's current EPS (TTM) is NZ$6.89. In 2025 the company made an earnings per share (EPS) of NZ$6.66 a decrease over its 2024 EPS that were of NZ$7.52.

EPS history for Prestige Consumer Healthcare from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ$6.731.03%
2025NZ$6.66-11.4%
2024NZ$7.52-367.08%
2023NZ-$2.82-138.33%
2022NZ$7.3511.7%
2021NZ$6.5813.6%
2020NZ$5.79-651.67%
2019NZ-$1.05-148.78%
2018NZ$2.15-83.29%
2017NZ$12.87437.23%
2016NZ$2.40-34.13%
2015NZ$3.6452.94%
2014NZ$2.38-8.11%
2013NZ$2.59
2011NZ$1.52

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$15.28 121.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Procter & Gamble
PG
NZ$12.23 77.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$12.28 78.17%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$2.29-66.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$6.31-8.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Clorox
CLX
NZ$10.81 56.85%๐Ÿ‡บ๐Ÿ‡ธ USA
CVS Health
CVS
NZ$4.04-41.37%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$6.80-1.36%๐Ÿ‡ฌ๐Ÿ‡ง UK
Rite Aid
RAD
NZ-$51.81-851.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Taro Pharmaceutical
TARO
NZ$2.13-69.04%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel